Fosstodon

Houston Public MediaHouston-based Empower Pharmacy is one of two compounding pharmacies sued by the pharmaceutical giant Eli Lilly earlier this month for allegedly selling “knockoff” versions of its weight loss and diabetes drugs.<a href="https://www.houstonpublicmedia.org/articles/news/health-science/medicine-wellness/2025/04/22/519463/eli-lilly-sues-houston-based-compounding-pharmacy-over-alleged-knockoff-obesity-diabetes-drugs/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.houstonpublicmedia.org/articles/news/health-science/medicine-wellness/2025/04/22/519463/eli-lilly-sues-houston-based-compounding-pharmacy-over-alleged-knockoff-obesity-diabetes-drugs/</a><a href="https://mastodon.social/tags/Business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Business</a> <a href="https://mastodon.social/tags/Court" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Court</a> <a href="https://mastodon.social/tags/HealthScience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#HealthScience</a> <a href="https://mastodon.social/tags/Healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Healthcare</a> <a href="https://mastodon.social/tags/Local" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Local</a> <a href="https://mastodon.social/tags/MedicineWellness" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MedicineWellness</a> <a href="https://mastodon.social/tags/News" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#News</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/EmpowerPharmacy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EmpowerPharmacy</a> <a href="https://mastodon.social/tags/FDADrugApproval" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#FDADrugApproval</a> <a href="https://mastodon.social/tags/Mounjaro" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Mounjaro</a> <a href="https://mastodon.social/tags/TirzepatideODT" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TirzepatideODT</a> <a href="https://mastodon.social/tags/Zepbound" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Zepbound</a>

The Japan TimesLilly licensed orforglipron from Chugai in 2018. Now both companies’ stocks are soaring as the pill shows potential for blockbuster status in the weight-loss drug market. <a href="https://www.japantimes.co.jp/business/2025/04/18/companies/weight-loss-drug-orforglipron/?utm_medium=Social&utm_source=mastodon" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.japantimes.co.jp/business/2025/04/18/companies/weight-loss-drug-orforglipron/?utm_medium=Social&utm_source=mastodon</a> <a href="https://mastodon.social/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#business</a> <a href="https://mastodon.social/tags/companies" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#companies</a> <a href="https://mastodon.social/tags/pharmaceuticals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pharmaceuticals</a> <a href="https://mastodon.social/tags/obesity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#obesity</a> <a href="https://mastodon.social/tags/mounjaro" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#mounjaro</a> <a href="https://mastodon.social/tags/ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ozempic</a> <a href="https://mastodon.social/tags/elililly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#elililly</a> <a href="https://mastodon.social/tags/chugai" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#chugai</a> <a href="https://mastodon.social/tags/orforglipron" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#orforglipron</a> <a href="https://mastodon.social/tags/health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#health</a>

La GriffeLes patrons de <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#NovoNordisk</a> <a href="https://mastodon.social/tags/pfizer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pfizer</a> <a href="https://mastodon.social/tags/elililly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#elililly</a> <a href="https://mastodon.social/tags/roche" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#roche</a> <a href="https://mastodon.social/tags/sanofi" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#sanofi</a> <a href="https://mastodon.social/tags/merck" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#merck</a> <a href="https://mastodon.social/tags/GSK" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GSK</a> ou encore <a href="https://mastodon.social/tags/Servier" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Servier</a> menacent de retirer des investissements d’ <a href="https://mastodon.social/tags/Europe" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Europe</a> Ils demandent de «raccourcir le processus pour les essais cliniques menés dans plusieurs pays» «suspendre et réviser la mise en œuvre» d’une directive qui vise à améliorer le traitement des eaux usées avant leur rejet dans la nature... <a href="https://www.ouest-france.fr/europe/ue/des-laboratoires-pharmaceutiques-menacent-de-retirer-des-investissements-deurope-5d860c16-1a2a-11f0-a759-74724e64dd56" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.ouest-france.fr/europe/ue/des-laboratoires-pharmaceutiques-menacent-de-retirer-des-investissements-deurope-5d860c16-1a2a-11f0-a759-74724e64dd56</a><a href="https://mastodon.social/tags/bigpharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#bigpharma</a> <a href="https://mastodon.social/tags/medicaments" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicaments</a> <a href="https://mastodon.social/tags/sante" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#sante</a>

Yonhap Infomax NewsJPMorgan forecasts potential tactical rebound in U.S. stock market, identifying key stocks like Eli Lilly that could lead the trend amid trade negotiations and market volatility <a href="https://mastodon.social/tags/YonhapInfomax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#YonhapInfomax</a> <a href="https://mastodon.social/tags/JPMorgan" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#JPMorgan</a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#StockMarket</a> <a href="https://mastodon.social/tags/TacticalRebound" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TacticalRebound</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/MarketVolatility" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MarketVolatility</a> <a href="https://mastodon.social/tags/Economics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Economics</a> <a href="https://mastodon.social/tags/FinancialMarkets" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#FinancialMarkets</a> <a href="https://mastodon.social/tags/Banking" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Banking</a> <a href="https://mastodon.social/tags/Securities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Securities</a> <a href="https://mastodon.social/tags/Bonds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Bonds</a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#StockMarket</a> <a href="https://en.infomaxai.com/news/articleView.html?idxno=57838" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://en.infomaxai.com/news/articleView.html?idxno=57838</a>

N-gated Hacker NewsWow, nothing like an "Access Denied" page to keep us on the edge of our seats! 😴 Apparently, Eli Lilly's weight loss <a href="https://mastodon.social/tags/pill" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pill</a> is so groundbreaking that even the internet doesn't have permission to know about it. 🚫🔍 <a href="https://mastodon.social/tags/SecretiveScience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SecretiveScience</a> <a href="https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html</a> <a href="https://mastodon.social/tags/AccessDenied" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AccessDenied</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/WeightLoss" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#WeightLoss</a> <a href="https://mastodon.social/tags/SecretiveScience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SecretiveScience</a> <a href="https://mastodon.social/tags/GroundbreakingInnovation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GroundbreakingInnovation</a> <a href="https://mastodon.social/tags/HackerNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#HackerNews</a> <a href="https://mastodon.social/tags/ngated" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ngated</a>

Hacker NewsEli Lilly will soon release key data on its weight loss pill orforglipron<a href="https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html</a><a href="https://mastodon.social/tags/HackerNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#HackerNews</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/Orforglipron" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Orforglipron</a> <a href="https://mastodon.social/tags/WeightLoss" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#WeightLoss</a> <a href="https://mastodon.social/tags/Pill" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pill</a> <a href="https://mastodon.social/tags/HealthInnovation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#HealthInnovation</a> <a href="https://mastodon.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrials</a>

Yonhap Infomax NewsNovo Nordisk's disappointing clinical trial results for advanced obesity treatment lead to sharp declines in Wegovy-related stocks, impacting both Novo Nordisk and competitor Eli Lilly <a href="https://mastodon.social/tags/YonhapInfomax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#YonhapInfomax</a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#NovoNordisk</a> <a href="https://mastodon.social/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://mastodon.social/tags/Wegovy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Wegovy</a> <a href="https://mastodon.social/tags/ObesityTreatment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ObesityTreatment</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/Economics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Economics</a> <a href="https://mastodon.social/tags/FinancialMarkets" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#FinancialMarkets</a> <a href="https://mastodon.social/tags/Banking" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Banking</a> <a href="https://mastodon.social/tags/Securities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Securities</a> <a href="https://mastodon.social/tags/Bonds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Bonds</a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#StockMarket</a> <a href="https://en.infomaxai.com/news/articleView.html?idxno=53688" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://en.infomaxai.com/news/articleView.html?idxno=53688</a>

VarietyImagine Entertainment and MACRO Partner With Eli Lilly to Bolster Film and TV Representation of Health Conditions <a href="https://mastodon.social/tags/Variety" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Variety</a> <a href="https://mastodon.social/tags/News" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#News</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/ImagineEntertainment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ImagineEntertainment</a> <a href="https://mastodon.social/tags/Macro" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Macro</a><a href="https://variety.com/2025/biz/news/imagine-entertainment-macro-eli-lilly-health-conditions-1236321896/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://variety.com/2025/biz/news/imagine-entertainment-macro-eli-lilly-health-conditions-1236321896/</a>

Yonhap Infomax NewsEli Lilly announces $27 billion investment in US manufacturing to meet rising demand for obesity and diabetes treatments, creating 10,000 jobs amid tariff concerns <a href="https://mastodon.social/tags/YonhapInfomax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#YonhapInfomax</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/ManufacturingInvestment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ManufacturingInvestment</a> <a href="https://mastodon.social/tags/ObesityTreatment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ObesityTreatment</a> <a href="https://mastodon.social/tags/DiabetesTreatment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#DiabetesTreatment</a> <a href="https://mastodon.social/tags/USJobCreation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#USJobCreation</a> <a href="https://mastodon.social/tags/Economics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Economics</a> <a href="https://mastodon.social/tags/FinancialMarkets" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#FinancialMarkets</a> <a href="https://mastodon.social/tags/Banking" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Banking</a> <a href="https://mastodon.social/tags/Securities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Securities</a> <a href="https://mastodon.social/tags/Bonds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Bonds</a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#StockMarket</a> <a href="https://en.infomaxai.com/news/articleView.html?idxno=52300" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://en.infomaxai.com/news/articleView.html?idxno=52300</a>

Jorro<a href="https://universeodon.com/tags/trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#trump</a> <a href="https://universeodon.com/tags/rfkjr" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#rfkjr</a> <a href="https://universeodon.com/tags/bigpharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#bigpharma</a> <a href="https://universeodon.com/tags/pfizer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#pfizer</a> <a href="https://universeodon.com/tags/elililly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#elililly</a> <a href="https://universeodon.com/tags/phrma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#phrma</a> <a href="https://universeodon.com/tags/corruption" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#corruption</a> It was a matter of time ,Trump though talk in public but soft in reality , Trump and Kennedy had dinner with big pharma but consumer advocates were not invited, go figure.<a href="https://www.axios.com/2024/12/05/trump-rfk-jr-pfizer-lilly" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.axios.com/2024/12/05/trump-rfk-jr-pfizer-lilly</a>

Autonomie und SolidaritätDer <a href="https://todon.eu/tags/CumEx" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CumEx</a>, Brechmittel Kanzler, dem es nur um das Wohl der Menschen geht.... <a href="https://todon.eu/tags/SPD" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SPD</a><a href="https://www.nd-aktuell.de/artikel/1185999.gesetzesaenderung-us-pharmakonzern-eli-lilly-ein-deal-mit-dem-teufel.html" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nd-aktuell.de/artikel/1185999.gesetzesaenderung-us-pharmakonzern-eli-lilly-ein-deal-mit-dem-teufel.html</a><a href="https://todon.eu/tags/Ampel" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Ampel</a> <a href="https://todon.eu/tags/Lobbyismus" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Lobbyismus</a> <a href="https://todon.eu/tags/Scholz" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Scholz</a> <a href="https://todon.eu/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://todon.eu/tags/Antireport" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Antireport</a>

ExTraders GlobalCaterpillar ($CAT) reported EPS of $5.17, below the forecast of $5.35. Revenue was $16.1B, slightly under the expected $16.37B.ADP ($ADP) achieved EPS of $2.33, surpassing the forecast of $2.21. Revenue reached $4.83B, exceeding the anticipated $4.77B.Eli Lilly ($LLY) reported EPS of $1.18, falling short of the forecast of $1.45. Revenue came in at $11.44B, below the anticipated $12.09B.<a href="https://mastodon.social/tags/Earnings" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Earnings</a> <a href="https://mastodon.social/tags/Q3" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Q3</a> <a href="https://mastodon.social/tags/Caterpillar" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Caterpillar</a> <a href="https://mastodon.social/tags/ADP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ADP</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/Investing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Investing</a> <a href="https://mastodon.social/tags/Finance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Finance</a> <a href="https://mastodon.social/tags/Stocks" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Stocks</a> <a href="https://mastodon.social/tags/MarketNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MarketNews</a>

nd.AktuellDokumente aus dem Gesundheitsministerium belegen: Das <a href="https://troet.cafe/tags/Medizinforschungsgesetz" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Medizinforschungsgesetz</a> wurde für die Firma <a href="https://troet.cafe/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> geändert – trotz Warnungen aus dem eigenen Ministerium. <a href="https://troet.cafe/tags/Pharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pharma</a> 👉 <a href="https://www.nd-aktuell.de/artikel/1186005.medizinforschungsgesetz-ein-gesetz-nur-fuer-lilly.html" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nd-aktuell.de/artikel/1186005.medizinforschungsgesetz-ein-gesetz-nur-fuer-lilly.html</a>

K. SchrageErleichtert die Bundesregierung dem US-Pharmakonzern <a href="https://troet.cafe/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> das Geldverdienen, im Gegenzug für den Bau einer Fabrik? Vieles spricht dafür. <a href="https://www.investigate-europe.eu/de/posts/wunsch-von-eli-lilly?utm_medium=email" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.investigate-europe.eu/de/posts/wunsch-von-eli-lilly?utm_medium=email</a>

Petrichor ᚄᚔᚅᚐᚁᚆᚃᚒᚔᚂUK's Labour (!!!) government is to use jobless people as guinea pigs for a pharmaceutical trial <a href="https://mastodon.ie/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://www.independent.co.uk/news/health/weight-loss-drugs-nhs-tirzepatide-mounjaro-b2629171.html" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.independent.co.uk/news/health/weight-loss-drugs-nhs-tirzepatide-mounjaro-b2629171.html</a>

Anja Reul 📯Dokumente des <a href="https://mastodon.social/tags/BMG" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#BMG</a>: "<a href="https://mastodon.social/tags/Bundesregierung" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Bundesregierung</a> (fügte sich) der Forderung des <a href="https://mastodon.social/tags/Pharmakonzern" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pharmakonzern</a>'s <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> (...), ein <a href="https://mastodon.social/tags/Gesetz" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Gesetz</a> zu dessen Gunsten zu ändern. Im Gegenzug flossen Milliarden-<a href="https://mastodon.social/tags/Investitionen" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Investitionen</a>."<a href="https://mastodon.social/tags/Gesundheit" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Gesundheit</a> / <a href="https://mastodon.social/tags/T%C3%B6dlichePreise" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TödlichePreise</a> „Wunsch von Eli Lilly“ <a href="https://www.investigate-europe.eu/de/posts/wunsch-von-eli-lilly" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.investigate-europe.eu/de/posts/wunsch-von-eli-lilly</a>

nd.AktuellFür ein paar Milliarden Euro kann man sich bei der Bundesregierung offenbar eine Gesetzesänderung kaufen – der US-<a href="https://troet.cafe/tags/Pharmakonzern" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Pharmakonzern</a> <a href="https://troet.cafe/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> hat es vorgemacht, kommentiert Pauline Jäckels. <a href="https://www.nd-aktuell.de/artikel/1185999.gesetzesaenderung-us-pharmakonzern-eli-lilly-ein-deal-mit-dem-teufel.html" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.nd-aktuell.de/artikel/1185999.gesetzesaenderung-us-pharmakonzern-eli-lilly-ein-deal-mit-dem-teufel.html</a>

The Japan TimesTwo new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled in one of the biggest medical controversies in recent years. <a href="https://www.japantimes.co.jp/news/2024/09/21/world/science-health/alzheimers-drugs-controversy/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.japantimes.co.jp/news/2024/09/21/world/science-health/alzheimers-drugs-controversy/</a> <a href="https://mastodon.social/tags/worldnews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#worldnews</a> <a href="https://mastodon.social/tags/sciencehealth" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#sciencehealth</a> <a href="https://mastodon.social/tags/dementia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#dementia</a> <a href="https://mastodon.social/tags/aging" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#aging</a> <a href="https://mastodon.social/tags/alzheimer039s" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#alzheimer039s</a> <a href="https://mastodon.social/tags/eisai" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#eisai</a> <a href="https://mastodon.social/tags/biogen" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#biogen</a> <a href="https://mastodon.social/tags/elililly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#elililly</a> <a href="https://mastodon.social/tags/drugs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#drugs</a> <a href="https://mastodon.social/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#medicine</a> <a href="https://mastodon.social/tags/brain" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#brain</a>

IT NewsEli Lilly raises price of Zepbound while trumpeting discount on starter vials - Enlarge / An Eli Lilly & Co. Zepbound injection pen arranged in the... - <a href="https://arstechnica.com/?p=2046139" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://arstechnica.com/?p=2046139</a> <a href="https://schleuss.online/tags/prescriptiondrugs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#prescriptiondrugs</a> <a href="https://schleuss.online/tags/healthinsurance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthinsurance</a> <a href="https://schleuss.online/tags/weightlossdrugs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#weightlossdrugs</a> <a href="https://schleuss.online/tags/berniesanders" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#berniesanders</a> <a href="https://schleuss.online/tags/drugprices" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#drugprices</a> <a href="https://schleuss.online/tags/elililly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#elililly</a> <a href="https://schleuss.online/tags/zepbound" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#zepbound</a> <a href="https://schleuss.online/tags/science" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#science</a> <a href="https://schleuss.online/tags/sanders" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#sanders</a> <a href="https://schleuss.online/tags/glp" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#glp</a>-1 <a href="https://schleuss.online/tags/lilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#lilly</a>

Pablonius Monk 🇺🇦"Some of the benefits appeared to last, however, only as long as patients were taking the drug."Eli Lilly Says Weight-Loss Drug Sharply Reduces Diabetes ProgressionThe drug also led to significant weight reductionWeekly injections of Zepbound for more than 3 years reduced the risk of progression to Type 2 diabetes by 94%, compared with a placebo, among people with excess weight and prediabetes.🎁🔗: <a href="https://www.wsj.com/health/pharma/eli-lilly-says-weight-loss-drug-sharply-reduces-diabetes-progression-96a1100b?st=sagm4pqvjdzy3b4&reflink=desktopwebshare_permalink" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.wsj.com/health/pharma/eli-lilly-says-weight-loss-drug-sharply-reduces-diabetes-progression-96a1100b?st=sagm4pqvjdzy3b4&reflink=desktopwebshare_permalink</a><a href="https://mastodon.social/tags/Zepbound" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Zepbound</a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#EliLilly</a> <a href="https://mastodon.social/tags/SemaGlutide" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SemaGlutide</a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GLP1</a> <a href="https://mastodon.social/tags/GutHormone" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GutHormone</a> <a href="https://mastodon.social/tags/Health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Health</a>

Recent searches

Search options

Administered by:

Server stats:

#elililly